Celling Biosciences is dedicated to the scientific understanding and therapeutic application of autologous cell therapy. Celling is fulfilling the promise that autologous cell therapy will bring physicians new clinical approaches and treatment options to address patient needs across a wide spectrum of preventative and regenerative medicine.
.png){kind=small}
.png)
Celling Biosciences is advancing medicine with cutting-edge research and innovation in point-of-care, autologous regenerative cell therapies.
Our expert team of scientists, physicians, and engineers spend countless time ideating and testing our products so each customer knows they are reliable, powerful, and the best on the market.
From minimizing sterile breaks to increasing cell concentrations per application, our products optimize the environment for regenerative cell therapies and enhance physician efficiency.
Lorem ipsum dolor sit amet consectetur. Fringilla mattis etiam tincidunt a accumsan eu proin risus. Non amet ut egestas orci at lacus nulla. Sed id consequat sed at. Felis ut parturient id amet ac. Suscipit nullam commodo nulla enim tristique ut ac etiam.
Lorem ipsum dolor sit amet consectetur. Fringilla mattis etiam tincidunt a accumsan eu proin risus. Non amet ut egestas orci at lacus nulla. Sed id consequat sed at. Felis ut parturient id amet ac. Suscipit nullam commodo nulla enim tristique ut ac etiam.
Lorem ipsum dolor sit amet consectetur. Fringilla mattis etiam tincidunt a accumsan eu proin risus. Non amet ut egestas orci at lacus nulla. Sed id consequat sed at. Felis ut parturient id amet ac. Suscipit nullam commodo nulla enim tristique ut ac etiam.
Lorem ipsum dolor sit amet consectetur. Fringilla mattis etiam tincidunt a accumsan eu proin risus. Non amet ut egestas orci at lacus nulla. Sed id consequat sed at. Felis ut parturient id amet ac. Suscipit nullam commodo nulla enim tristique ut ac etiam.
.png)
.png){kind=small}
2005: Celling Biosciences is Founded in Austin, TX.
Founded by Kevin Dunworth, Celling is fulfilling the promise that autologous cell therapy will bring physicians new clinical approaches and treatment options to address patient needs across a wide spectrum of preventative and regenerative medicine.